ASCO GU 2026

SUZHOU, China, February 26, 2026 ImmVira Group announced encouraging preliminary clinical data for its oncolytic virus candidate MVR-T3011 in...

RAHWAY, N.J., Feb. 12, 2026 — Merck & Co. announced the presentation of extensive new clinical data in bladder...